
TM · NYSE
The supplied consensus is Buy across six analysts. Reported targets are low 221, mean 230 and high 221, but those figures are internally inconsistent because the stated high is below the mean; they therefore do not establish a reliable target cluster or spread. The evidence does not identify which analyst is most or least bullish. The only explicitly attributable revision was Freedom Broker’s downgrade to Hold and target reduction from 232 to 221, indicating a more cautious direction over the available period. The substantive disagreement is between the six-analyst Buy consensus and Freedom Broker’s Hold, while the underlying evidence does not explain the valuation difference or provide operating estimates to resolve it.
| Firm | Analyst | Rating | Price Target | Upside | Date | Source |
|---|---|---|---|---|---|---|
| Freedom Broker | — | $221 | +11.9% | Aug 20, 2026 | Open the report this row came from | |
| Freedom Broker | — | $221 | +11.9% | Aug 10, 2026 |
| Freedom Broker | — | $221 | +11.9% | Jul 31, 2026 | Open the report this row came from |